Pharmaceutical Care of Listeria Meningitis in a Child with Normal Immunity

doi:10.19803/j.1672-8629.2020.09.16

Abstract

Abstract: Objective To explore the role of clinical pharmacists in the treatment of children with Listeria monocytogenes meningitis. Methods Clinical pharmacists participated in the medication of a child with Listeria monocytogenes meningitis. Pharmaceutical care involved the selection of antibiotics, drug dosage, adverse drug reactions, therapeutic effect and course of treatment. Results The patient got better and was discharged from the hospital Eventually. Conclusion Participation of clinical pharmacists in clinical treatment can provide individualized treatment for patients, which can help improve clinical treatment and promote rational drug use.Keywords: children; Listeria monocytogenes meningitis; pharmaceutical care

CLC Number:

R994.11

YANG Xue, FANG Lingzhi, WEI Lina, JI Hongyan, DONG Lei. Pharmaceutical Care of Listeria Meningitis in a Child with Normal Immunity[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 622-624.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.2020.09.16

https://zgywjj.magtechjournal.com/EN/Y2020/V17/I9/622

References

[1] 《抗菌药物临床应用指导原则》修订工作组.抗菌药物临床应用指导原则[M].北京:人民卫生出版社,2015:60-61.
[2] 何礼贤,肖永红,陆权,等.国家抗微生物治疗指南[M].2版.北京:人民卫生出版社,2017: 7.
[3] 桑福德.热病:桑福德抗微生物治疗指南[M].44版.范洪伟译.北京:中国协和医科大学出版社,2016:9.
[4] 迈克沙兰. 儿童抗感染性疾病蓝皮书[M].3版.申昆玲等译.北京:科学文献技术出版社,2015:610.
[5] 杨建伟. 单核细胞增生性李斯特菌最新研究进展[J].齐鲁医学杂志,2013,10(5):465-467.
[6] 孙照琨,吴璇,陈蕊,等.李斯特菌病既往中国文献报告病例分析[J].中国微生态学杂志,2016,28(11):1323-1325.
[7] Cohen SH,Gerding DN,Johnson S,et al.Clinical practice guidelines for clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)[J]. Infect Control Hosp Epidemiol,2010,31(5) : 431-455.
[8] 约翰惠普金斯.ABX指南[M].2版.北京:科学技术文献出版社,2012:654.
[9] van de Beek D, Cabellos C, Dzupova O, et al. diagnosis and treatment of acute bacterial meningitis[J]. Clinical Microbiology and Infection, 2016,22(3):37-62.
[10] Krawczyk Balska A,Markiewicz Z.The intrinsic cephalosporin resistome of Listeria monocytogenes in the context of stress response, gene regulation, pathogenesis and therapeutics[J]. Journal of Applied Microbiology,2015,120:251-265.
[11] 杨建伟. 单核细胞增生性李斯特菌最新研究进展[J].齐鲁医学杂志,2013,28(5):465.
[12] 王文娟,刘晶,赵金辉.感染产单核李斯特菌的孕妇临床特点及药敏分析[J].现代检验医学,2010,25(2): 131-133.
[13] 刘桂华,黄鑫,张炜煜.食品中金黄色葡萄球菌和单核细胞增生李斯特菌抗药性检测及结果分析[J]. 中国卫生工程学,2018, 17(4): 497-498.
[14] Pasquale P, Ferhat A, Tiziana A.Epidemiology and treatment of the commonest form of listeriosis:meningitis and bacteraemia[J].Le Infezioni in Medicina,2017,25(3):210-216.

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.